JPRN-UMIN000004729
Completed
Phase 1
Phase I/II study of combination chemotherapy with Paclitaxel and TS-1 and Cisplatin for unresectable/ recurrent gastric cancer - Phase I/II study of combination chemotherapy with Paclitaxel and TS-1 and Cisplatin
Conditionsunresectable or recurrent gastric cancer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- unresectable or recurrent gastric cancer
- Sponsor
- School of Medicine, Keio University
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) with heart disease needed to treat (ex. ischemic cardiac disease, arrhythmia) Left ventricular hypertrophy according to high blood pressure, slight left ventricle load, slight right bundle branch block are acceptable. 2\) Cardiac infarction that developed within six months 3\) Cirrhosis and hepatitis of briskness 4\) Breathing difficulties that require oxygen administration by interstitial pneumonia and lungs fiber syndrome, etc. 5\) Gut freshness hemorrhage that repeatedly requires transfusion 6\) with clinically important mental disorder need to treat or treating with mind drug 7\) with uncontrollable diabetes mellitus 8\) with intestinal obstruction and sub\-intestinal obstruction 9\) infection with fever or doubt it 10\) Double cancer of briskness 11\) brain metastasis with symptom 12\) Acute inflammatory disorder 13\) Peripheral neuropathy 14\) history of severe drug anaphylaxis 15\) history of severe anaphylaxis to drug included Cremohor EL or Stiffening castor oil 16\) pregnant woman, breast\-feeding woman, and possibility of pregnancy 17\) doctor's decision not to be registered to this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Phase I-II study of combination chemotherapy with Irinotecan and Gemcitabine for clear cell or mucinous ovarian cancerClear cell or mucinous ovarian cancerJPRN-UMIN000005952Osaka university, faculty of medicine40
Completed
Phase 1
A phase I study of the combination chemotherapy of IRISOX (irinotecan/S-1/oxaliplatin) in gemcitabine-refractory pancreatic cancergemcitabine-refractory pancreatic cancerJPRN-UMIN000022964Kitasato University School of Medicine12
Completed
Phase 2
A Phase II study of combination chemotherapy with TS-1 and Trastuzumab for patients with HER2 positive advanced or recurrent gastric cancer.advanced or recurrent gastric cancerJPRN-UMIN000008220Osaka medical center for cancer and cardiovascular diseases20
Completed
Phase 2
A phase II study of combination chemotherapy with carboplatin plus S-1 in advanced lung squamous cell carcinomaung cancerJPRN-UMIN000006983Hamamatsu University School of Medicine50
Completed
Phase 2
A phase II study of combination chemotherapy with carboplatin plus S-1 in advanced and recurrence non small cell lung cancernon-small-cell lung cancerJPRN-UMIN000010189ational Hospital Organization Osaka20